Sudan's Mahdi: We Are Ready to Hold Dialogue with Government

Head of the National Umma Party (NUP) and president of Nidaa Sudan Sadiq al-Mahdi. Asharq Al-Awsat Arabic
Head of the National Umma Party (NUP) and president of Nidaa Sudan Sadiq al-Mahdi. Asharq Al-Awsat Arabic
TT

Sudan's Mahdi: We Are Ready to Hold Dialogue with Government

Head of the National Umma Party (NUP) and president of Nidaa Sudan Sadiq al-Mahdi. Asharq Al-Awsat Arabic
Head of the National Umma Party (NUP) and president of Nidaa Sudan Sadiq al-Mahdi. Asharq Al-Awsat Arabic

The head of the National Umma Party (NUP) and president of Nidaa Sudan, Sadiq al-Mahdi, confirmed the readiness of the coalition to hold dialogue with the government of President Omar al-Bashir.

Mahdi told Asharq Al-Awsat that dialogue with the government "is taking place through the African mechanism," describing the unification of the opposition as "utopian".

Mahdi said there were several conditions to coordinate with opposition forces, such as rejecting any quest to oust the regime by force, sidestepping demands of self-determination, avoiding seeking support from Israel, or standing against the opposition.

Asking Mahdi whether he thinks the government will arrest him once he goes back to the country, he said that "the government has gotten used to dealing with us inconsistently... It offered us participatation in the highest levels and highest ratios, but we rejected any participation that is not based on just and comprehensive peace and democratic transformation.

Now the government has issued six notices against me, Mahdi added.

The newspaper said that the power balance is now in favor of Sudanese President Omar al-Bashir while the opposition is inactive, however, Mahdi questioned the standards of the balance of power denouncing the fact that the regime, and after 30 years, has failed in all fields and is now on the verge of an economic bankruptcy.

Responding to the newspaper’s question whether there is an initiative to unite the opposition forces, he stressed that such an aspiration is far from reality but the bulk part of the opposition is Nidaa Sudan and it is coherent.

Speaking about the reconciliation with president Gaafar al-Nimeiry (1969, 1985) mid-seventies and the current agreements with Bashir not to mention the criticism for dealing with the military systems, Mahdi said that only illusionists refused dialogue with the systems. He stressed that the national strugglers held a dialogue with the foreign occupation countries from which transformation to independence resulted.

Asking how he viewed the future of Sudan amid the internally, regionally and internationally complex conditions, Mahdi said that the Sudanese human capital is perfect as well as the natural resources. Mahdi continued that the political forces agree on two significant matters: steadiness and forgiveness that make the ideologists more lenient than others outside Sudan. These components can achieve an agreement similar to the Convention for a Democratic South Africa (CODESA) or a peaceful revolution such as October revolution 1964, he added.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.